$TEAM, $DRD, $HZO, $NEWR, $NOW, $PSTI, $SPLK
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is our list for Wednesday, 15 April, as follows:
Atlassian Corp. PLC (NASDAQ:TEAM) was reiterated as Buy with a 162 price target at SunTrust Robinson Humphrey.
DRDGold Ltd. (NYSE:DRD): gold miners are benefiting greatly from gold prices. Shares recently closed at 8.81 and have a consensus price target of 9.25
MarineMax Inc. (NYSE:HZO) was reiterated as Buy and its price target was raised to 14 from 12 at SunTrust Robinson Humphrey.
New Relic Inc. (NYSE:NEWR) was maintained as Buy but the price target was cut to 75 from 85 at SunTrust Robinson Humphrey.
Pluristem Therapeutics Inc. (NASDAQ:PSTI) was reiterated as Buy with a 12 price target at Dawson James, which noted that the FDA cleared its compassionate use using PLX cells to treat its first COVID-19 patient in the United States.
ServiceNow Inc. (NYSE:NOW) was maintained as Buy but the price target was cut to 350 from 380 at SunTrust Robinson Humphrey.
Splunk Inc. (NASDAQ:SPLK) was maintained as Buy but the price target was cut to 180 from 190 at SunTrust Robinson Humphrey
Have a healthy day, Keep the Faith!